Summary
Bone mineral density (BMD), serum osteocalcin and type I collagen C-telopeptide (ICTP) were assessed in a cohort of 31 (16 males) adults who had received cranial irradiation in childhood as part of their treatment for acute lymphoblastic leukaemia (ALL). Markers of bone turnover were compared with those of 35 age and body mass index (BMI) matched young adults (18 male). Growth hormone status had previously been determined using an insulin tolerance test and arginine stimulation test. Eight patients were classified as severe growth hormone deficiency (group 1), 12 patients as growth hormone insufficient (group 2) and 11 patients as normal (group 3). Vertebral trabecular BMD, lumbar spine and femoral neck integral BMD and forearm cortical bone mineral content (BMC) was measured 17.8 (6.8–28.6) years after cranial irradiation and was expressed as Z (standard deviation) scores. There was a significant reduction in vertebral trabecular BMD (median Z score –1.25, P < 0.001), in lumbar spine integral BMD (median Z score –0.74, P = 0.001), in forearm cortical BMC (median Z score –1.35, P < 0.001), and less so in femoral neck integral BMD (median Z score –0.43, P = 0.03). There was no difference among the growth hormone status groups for the following BMD measurements: vertebral trabecular BMD, lumbar spine integral BMD or femoral neck integral BMD (P = 0.8, P = 0.96 and P = 0.4 respectively). There was only a marginal significant difference for BMD at the wrist between growth hormone status groups (P = 0.04). There was no correlation between the BMD measurements with time since or age at diagnosis and no difference in markers of bone turnover between patients and controls; median serum osteocalcin 13.3 and 12.0 ng ml (P = 0.7), respectively, and for ICTP 5.0 and 4.9 μg L (P = 0.67) respectively. In conclusion, there is a highly significant reduction in BMD in young adults following treatment for ALL in childhood. The reduction in BMD affects both trabecular and cortical bone but did not seem to be related to time since diagnosis, age at diagnosis, or current growth hormone status. Possible explanations include a direct effect of chemotherapy, steroids or both on bone during childhood and hence an effect on the accretion of bone mass. In view of the risk of fractures in patients with osteopenia, adults treated for ALL in childhood may be at an increased risk of bone fractures later in life irrespective of the underlying cause of the osteopenia and thus intervention should be considered.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Adams, J. E. & Adams, P. H. (1988). The measurement of spinal bone mass by quantitative computed tomography: assessment of precision and different calibration phantoms. Br J Radiol 61: 724
Baylink, D. J. (1983). Glucocorticoid-induced osteoporosis. N Engl J Med 309: 306–308.
Block, J. E., Smith, R., Glueer, C-C, Steiger, P., Ettinger, B. & Genant, H. K. (1989). Models of spinal trabecular bone loss as determined by quantitative computed tomography. J Bone Miner Res 4: 249–257.
Brennan, B. M. D., Rahim, A., Mackie, E. J., Eden, O. B. & Shalet, S. M. (1998). Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood. Clin Endocrinol 48: 777–784.
Callum, I. D., Ell, P. J. & Ryder, J. P. (1989). X ray dual-photon absorptiometry: a new method for the measurement of bone density. Br J Radiol 62: 587–592.
Cann, C. E. & Genant, H. K. (1980). Precise measurement of vertebral mineral content using computed tomography. J Comput Assist Tomogr 4: 493–500.
Chessells, J. M., Bailey, C. & Richards, S. (1995). Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Lancet 345: 143–148.
Cummings, S. R., Black, D. M., Nevitt, M. C., Browner, W., Cauley, J., Ensrud, K., Genant, H. K., Palermo, L., Scott, J. & Vogt, T. M. (1993). Bone density at various sites for prediction of hip fractures. Lancet 341: 72–75.
De Boer, H., Block, G. J., Lingen, A. V., Teule, G. J. J., Lips, P. & Van Der Veen, E. A. (1994). Consequences of childhood-onset growth hormone deficiency for adult bone mass. J Bone Miner Res 9: 1319–1327.
Faulkner, K. G., Gluer, C-C, Grampp, S. & Genant, H. K. (1993). Cross-calibration of liquid and solid QCT calibration standards: corrections to the UCSF normative data. Osteoporosis Int 3: 36–42.
Friedlaender, G. E., Tross, R. B., Doganis, A. C., Kirkwood, J. M. & Balon, R. (1984). Effects of chemotherapeutic agents on bone. 1. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model. J Bone Joint Surg 66A: 602–607.
Genant, H. K., Cann, C. E., Pozzi-Mucelli, R. S. & Kanter, A. S. (1983). Vertebral mineral determination by quantitative CT: clinical feasibility and normative data. J Comput Assist Tomogr 7: 554
Gilsanz, V., Carlson, M. E., Roe, T. F. & Ortega, J. A. (1990). Osteoporosis after cranial irradiation for acute lymphoblastic leukaemia. J Pediatr 117: 238–244.
Halton, J. M., Atkinson, S. A., Fraher, L., Webber, C., Gill, G. J., Dawson, S. & Barr, R. D. (1996). Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukaemia. J Bone Miner Res 11: 1774–1783.
Holmes, S. J., Whitehouse, R. W., Clark, S. T., Crowther, D. C., Adams, J. E. & Shalet, S. M. (1994a). Reduced bone mineral density in men following chemotherapy for Hodgkin’s disease. Br J Cancer 70: 371–375.
Holmes, S. J., Economou, G., Whitehouse, R. W., Adams, J. E. & Shalet, S. M. (1994b). Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 78: 669–674.
Kaufman, J. M., Taelman, P., Vermeulen, A. & Vandeweghe, M. (1992). Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 74: 118–123.
Kreuser, E. D., Felsenberg, D., Behles, C., Seibt-Jung, H., Mielcarek, M., Diehl, V., Dahmen, E. & Thiel, E. (1992). Long term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin’s disease. Ann Oncol 3: 105–110.
Lukert, B. P. & Raisz, L. G. (1990). Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112: 352–364.
Nussey, S. S., Hyer, S. L., Brada, M. & Leiper, A. D. (1994). Bone mineralization after treatment of growth hormone deficiency in survivors of childhood malignancy. Acta Paediatr Suppl 399: 9–14.
O’Halloran, D. J., Tsatsoulis, A., Whitehouse, R. W., Holmes, S. J., Adams, J. E. & Shalet, S. M. (1993). Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 76: 1344–1348.
Parfitt, A. M. (1990). Interpretation of bone densitometry measurements: disadvantages of a percentage scale and a discussion of some alternatives. J Bone Miner Res 5: 537–540.
Peretz, A., Praet, J-P, Bosson, D., Rozenberg, S. & Bourdoux, P. (1989). Serum osteocalcin in the assessment of corticosteroid induced osteoporosis. Effect of long and short term corticosteroid treatment. J Rheumatol 16: 363–367.
Prentice, A., Parsons, T. J. & Cole, T. J. (1994). Uncritical use of bone mineral density in absorptiometry may lead to size-related artefacts in the identification of bone mineral determinants. Am J Clin Nutr 60: 837–842.
Reid, I. R. & Grey, A. B. (1993). Corticosteroid osteoporosis. Bailliere Clin Rheumatol 7: 573–587.
Rosen, T., Hansson, T., Granhed, H., Szucs, J. & Bengtsson, B-Å (1983). Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol 129: 201–206.
Stepan, J. J., Lachman, M., Zverina, J., Pacovsk, V. & Baylink, D. J. (1989). Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodelling. J Clin Endocrinol Metab 69: 523–527.
Tanner, J. M., Whitehouse, R. H. & Takaishi, M. (1965a). Standards from birth to maturity for height, weight, height velocity and weight velocity: British children. Arch Dis Childhood 41: 454–457.
Tanner, J. M., Whitehouse, R. H. & Takaishi, M. (1965b). Standards from birth to maturity for height, weight, height velocity and weight velocity: British children. Arch Dis Childhood 41: 613–635.
Thomsen, K., Gotfredsen, A. & Christiansen, C. (1986). Is postmenopausal bone loss an age-matched phenomenon? Calcif Tissue Int 39: 123–127.
Whitehouse, R. W., Adams, J. E., Bancroft, K., Vaughan-Williams, C. A. & Elstein, M. (1990). The effects of nafarelin and danazol on vertebral trabecular bone mass in patients with endometriosis. Clin Endocrinol 33: 365–373.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Brennan, B., Rahim, A., Adams, J. et al. Reduced bone mineral density in young adults following cure of acute lympblastic leukaemia in childhood. Br J Cancer 79, 1859–1863 (1999). https://doi.org/10.1038/sj.bjc.6690296
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690296
Keywords
This article is cited by
-
Neurocognitive impairment in Asian childhood cancer survivors: a systematic review
Cancer and Metastasis Reviews (2020)
-
Bone Mineral Density Deficits and Fractures in Survivors of Childhood Cancer
Current Osteoporosis Reports (2013)
-
Efficacy of the Survivor Health and Resilience Education (SHARE) Program to Improve Bone Health Behaviors Among Adolescent Survivors of Childhood Cancer
Annals of Behavioral Medicine (2011)
-
Pediatric DXA: technique, interpretation and clinical applications
Pediatric Radiology (2008)
-
Pediatric DXA: clinical applications
Pediatric Radiology (2007)